guangzhou pharmaceuticals
when guangzhou pharmaceuticals group took over 90% stockholdings of the club in 2006, they were still unable to realize their ambition of gaining promotion after finishing only third in the league .
guangzhou pharmaceuticals corporation has under it the headquarters, five wholly owned subsidiaries: guangzhou guoying pharmaceutical company, guangzhou xinte pharmaceutical company, guangzhou jianmin chain store company, guangzhou qihua medical device company, shenzhen liankang pharmaceutical company, six controlling subsidiaries: hubei guangyao ankang pharmaceutical company, fujian jieda pharmaceutical company, foshan guangyao jianze pharmaceutical company, hunan guangyao hengsheng pharmaceutical company, hainan guangyao chenfei pharmaceutical company, shaanxi guangyao kangjian pharmaceutical company, and dazhong pharm retail stores .
the investment is to target the rapidly growing chinese pharmaceuticals market, which alliance boots expects to become the world’s sixth largest by 2010 from ninth currently .
alliance boots plc, a leading pharmacy - led health and beauty group, today announces that it has reached an agreement to form a 50: 50 joint venture in guangzhou pharmaceuticals corporation (
gp corp
), the third largest pharmaceutical wholesaler in china .
guangzhou pharmaceutical company ltd is principally engaged in the manufacture and sale of chinese patent medicine; wholesale, retail, import and export of western and chinese pharmaceutical products and medical apparatus; and research and development of natural medicine and biological medicine. guangzhou pharmaceutical company ltd is a state - owned pharmaceutical enterprise under the guangzhou municipal government, the h shares of which were listed on the hong kong stock exchange in 1997 and the a shares of which were listed on the shanghai stock exchange in 2001. currently guangzhou pharmaceutical company ltd owns 90% of guangzhou pharmaceuticals corporation which is engaged in pharmaceutical wholesaling and distribution .
add: 22 / f. evergrande international center, no. 78 huangpu avenue west, guangzhou, p. r. china, 510620 guangzhou evergrandetaobao football club e - mail：gzevergrandefc @ urltoken
in 2002, the guangzhou sports bureau took over the club once again, and the name of the club was changed into guangzhou xiangxue after receiving an 8 million yuan investment from the xiangxue pharmaceuticals group. the club mainly focused on the development of young players during that season and as a result, they finished 11th in the end. yet the xiangxue group continued their investment in the following year and with 8 million yuan flowing into the club, guangzhou xiangxue reached 3rd place in the 2003 season .
guangzhou pharmaceuticals corporation was founded in y1951 with a registered capital of rmb 700 million. being the largest sino - foreign joint venture enterprise in china, it is not only a key member of the leading enterprises under guangzhou pharmaceutical holdings limited (gphl), but also a member of alliance boots. we are committed to the health care of the public and endeavored to the scientific development of pharmaceutical industry .
on 1 march 2010, the evergrande group took over guangzhou fc for a fee of ￥100 million and the name of the club was officially changed as guangzhou evergrande fc. the club returned to the top flight after winning the china league one with three rounds remaining in the league, which brought back hope for the football fans in guangzhou
on 23 february 2010, however, guangzhou was relegated back to the china league one in the fallout of a match - fixing scandal that took place in 2006 season. the club was later taken over by the guangzhou fa .
at present, guangzhou evergrande taobao fc is believed to be the most successful and most influential football club in asia .
guangzhou football team finished 8th in the 1st chinese fa cup held in 1984 and were able to return to the top division at the end of that year. with this promotion, the team became the first chinese team to gain sponsorship from enterprises when guangzhou pharmaceutical co. , ltd. signed a $ 200, 000 annual deal with the guangzhou sports bureau in october 1984. and it was the guangzhou pharmaceutical holdings, which later became the parent company of guangzhou pharmaceutical co. , ltd. , that took over the club 22 years later and brought the club to the top division .
the formation of the joint venture is conditional upon receiving approval from guangzhou pharmaceutical shareholders, and various government and regulatory approvals .
alliance boots' partner in the joint venture will be guangzhou pharmaceutical company ltd, a majority state - owned pharmaceutical enterprise which is listed on the hong kong and shanghai stock exchanges. guangzhou pharmaceutical company ltd currently owns 90% of gp corp .
pharmacy group alliance boots is to form a joint venture with guangzhou pharmaceutical (gp), the third largest pharmaceutical wholesaler in china .
in 2004, the sunray cave group took over 70% stock shares of the club after paying a symbolic fee of 1 yuan, and became the largest shareholder of the club. the name of guangzhou fc was officially changed into “guangzhou sunray cave zhongyi pharmaceutical fc” after receiving a 6 - million - yuan title sponsorship from guangzhou zhongyi pharmaceutical company. with another 6. 5 million yuan from teemall group and guangzhou urban construction group being invested to the club in the following year, guangzhou fc was able to bring in several talented foreign players during the two years. however, they failed to promote to the first division in both seasons despite only losing four matches in each season .
at the beginning of the 2016 season, guangzhou won their second chinese super cup with a 2 - 0 victory over jiangsu suning fc in february .
china is the ninth largest pharmaceutical market in the world. it is experiencing rapid economic growth which is driving even higher growth rates for healthcare expenditure. as a result, china is expected to be the sixth largest pharmaceuticals market by 2010. the chinese pharmaceutical wholesale and distribution market is fragmented and largely regionally - based and principally involves supply to hospital pharmacies .
london (reuters) - alliance boots said on monday it had agreed to form a 50 - 50 joint venture with guangzhou pharmaceutical co. to enter the chinese market .
starting from 1992, the chinese football association launched a structural reform for professionalism in china. on 8 january 1993, guangzhou became the first joint - stock professional football club in china after the apollo group took over the club from the guangzhou sports bureau, and would participate in the c league – the top tier professional league after the reforms – in the following year .
in 2001, a new guangzhou fc was formed after merging with guangzhou matsunichi, who relegated to the second division in the previous season. with significant investment coming from the zhejiang geely holding group, guangzhou fc were able to finish 4th at the end of that season. it was hoped that the club could push for promotion due to a match - fixing scandal involving the runners - up and the third place. yet things were not going on the way as expected. in the end, the new sponsor geely pulled their funding away from the club to distant themselves from the bad publicity .
however, the club went through a period of stagnation and decline afterwards. the club came last in the race and was relegated in the 1998 league season after winning only 20 points during that season, and for a very long time since then, guangzhou fc could only play in the second tier league. peng weiguo, an influential international footballer of guangzhou fc, blamed the free fall of the club on the lack of investment. indeed, the amount of investment for guangzhou fc during that time was relatively small while professional football was being considered to be an activity which requires a large amount of investment .
yet the club was unable to replicate the same result in the following season due to the change of the head coach and conflicts within the club, and finished 5th in that season. the second team of the club was sold to matsunichi in 1996, leading to an unprecedented occasion in which three clubs from guangzhou are competing in the c league together. however, guangzhou apollo fc experienced another downfall during that year. they finished only 7th by the end of that season. with 9 players leaving the club after the disastrous 1996 season, guangzhou could barely maintain their position in the top league in 1997 .
alliance boots said on monday it had agreed to form a 50 - 50 joint venture with guangzhou pharmaceutical co. to enter the chinese market. file photo shows alliance boots ceo richard baker. reuters / vismedia
founded in june 1954, guangzhou football team is the first municipal football team in china. the team later became the first professional football club in china to be operated by both the government and an enterprise after its cooperation with the apollo group in january 1993. back in the 1990s, guangzhou apollo fc, along with guangdong winnerway fc, was major clubs in the chinese top tier league ever since the reform for professionalism in football clubs in 1994. guangzhou apollo fc even finished their 1994 season of the c league (which was the top tier league in china back then) in the runners - up’s spot with 27 points .
alliance boots ab. l said it would buy a 50 percent interest in gp corp, china’s third - biggest pharmaceutical wholesaler, for 38 million pounds. gp is currently 90 percent owned by guangzhou pharmaceutical co .
in 1986, qi wusheng was named head coach of guangzhou baiyun football team. the team later developed into a football club in 1989, yet only came last in the race and was relegated from the c league .
unlike in india, it’s become increasingly difficult for fda to obtain visas for its inspectors in china and in 2014, fda closed two of its offices in shanghai and guangzhou, china, and consolidated operations at its beijing location .
gp corp has powerful warehouses to store prescription drugs, otc drugs, essential drugs and healthcare products, which can meet all demands of various customers. we provide distribution services to around 4000 health care institutions, 1800 drug stores, and nearly 2900 retailers nation - wide. in the meantime, we are authorized to be the sponsor of pharmaceutical reservation for guangzhou municipality and guangzhou army, supplier of first - aid medicines for guangdong province, and the exclusive distributor of medical devices in the 16th asian games .
the formation of the joint venture, which is conditional upon receiving guangzhou pharmaceutical company ltd shareholder approval and various government and regulatory approvals, is expected to be completed in the second half of 2007 and will expand alliance boots' wholesale presence to 15 countries .
yang rongming, chairman of the joint venture partner, guangzhou pharmaceutical company ltd, said :
we are delighted to be forming this joint venture with such an experienced international partner with proven excellence in the operation, acquisition and integration of pharmaceutical distribution businesses .
the club set a domestic record for the longest run of 44 unbeaten league matches during the 2011 season and immediately clinched the league title of that season despite there were four games yet to play. this became the first top division title in the history of guangzhou fc .
guangzhou evergrande taobao fc made their initial public offering in 2015, which made them the first asian football club to go on public. they eventually claimed their fifth consecutive chinese super league titles after staying unbeaten for 26 consecutive rounds, as well as their second continental championship in three years. the club finished fourth in the 2015 fifa club world cup in japan .
in 1999, the apollo group signed a 5 - year new deal with guangzhou sports bureau. however, the club only finished 8th in the second division at the end of that season. the recession continued in the 2000 season with no signs of recovery, although the club had invested more than 20 million yuan before the season started. as the result of their downturn at the beginning that season, guangzhou would have to defeat beijing kuanli in the last round of the league in order to avoid the tragedy of relegation. and thanks to zeng qinggao’s last minute goal, the club barely survived that season. thousands of supporters rushed into the field after the final whistle, and the players, as well as team officials, all burst into tears .
in the 2013 season, by scoring 78 goals and winning 77 points unprecedentedly in the league, guangzhou evergrande fc claimed the domestic league title three times in a row with three rounds yet to play. the club also won the 2013 afc champions league title, becoming the first chinese side to win the tournament ever since the reforming of chinese football clubs. later, the club finished fourth place in the 2013 fifa club world cup .
however, with chen yiming becoming the head coach, guangzhou baiyun fc came back to the top league for the third time in the following season. and thanks to zhou suian, who was still a young coach back then, and players such as mai chao, wu liqun, li yong, as well as young talents such as peng weiguo, the club was able to secure a runners - up position in the 1992 season. this was the best record for the club before the reform of professionalism in chinese football industries .
when peng weiguo and hu zhijun left the club in 1998, the club could not recover from the change as they had already sold out their second team. to make things worse, the club was unable to compete with those clubs being supported by state - owned enterprises. guangzhou apollo went into a free fall and was relegated at the end of the 1998 league season. with the management concerned about the team' s insipid display, an investigation was launched which discovered that some players were in collusion with gambling groups and were immediately expelled from the club .
“the chinese market has good growth potential and this move demonstrates our belief in the ability of the group to drive growth through developing opportunities in new markets, ” alliance boots chief executive richard baker said in a statement .
alliance boots is the latest british firm to set up shop in china, seeking to benefit from its booming consumer economy amid forecasts of slowing consumption at home. tesco (
), britain’s biggest retailer and the world’s fifth largest, on friday opened its first own - brand chinese supermarket in beijing .
“it looks like a sensible acquisition, but, given the neutral effect on the profit and loss, it should be negligible on the valuation of boots, ” seymour pierce analyst richard ratner wrote in a note .
on completion of the alliance boots deal, the venture, which has 9 depots and controls around 3 percent of the chinese pharmaceutical wholesale market, will operate 29 retail pharmacies, the maximum permitted under the current regulations for a 50 - 50 foreign joint venture .
alliance boots said it would make the investment through a uk subsidiary in which u. s. - listed beijing med - pharm corp holds 20 percent .
the venture is expected to be completed in the second half of 2007 and will boost alliance boots’s wholesale presence to 15 countries .
shares in alliance boots, created from the merger of retailer boots and drugs wholesaler alliance unichem in july, traded slightly lower at 820 pence per share by 10: 05 a. m. , in line with the dj stoxx index of european retailers. sxrp .
for inquiries related to this message please contact support. for sales inquiries, please visit urltoken
if you believe this to be in error, please confirm below that you are not a robot by clicking
i' m not a robot
below .
please make sure your browser supports javascript and cookies and that you are not blocking them from loading. for more information you can review the terms of service and cookie policy .
doctype html public
- / / w3c / / dtd html 4. 0 transitional / / en
urltoken
the joint venture will run 29 retail pharmacies in china, the most permitted under chinese rules for such a deal .
gp is the leading wholesaler in its home province of guangdong where it has a market share of about 16% . it also has a 3% share of the national market .
it underlies our commitment to be a major international player in pharmacy - led health and beauty ,
he said .
the chinese market has good growth potential and this move demonstrates our belief in the ability of the group to drive growth through developing opportunities in new markets .
boots, whose retail arm is in nottingham, said the joint venture would bring together strong local management and
our extensive experience in running pharmaceutical wholesaling businesses
.
yang rongming, chairman of the joint venture partner, said :
we are delighted to be forming this joint venture with such an experienced international partner with proven excellence in the operation, acquisition and integration of pharmaceutical distribution businesses .
it is expected to be completed in the second half of 2007 and will expand alliance boots' wholesale presence to 15 countries .
most popular now | 56, 514 people are reading stories on the site right now .
;
most popular now | 17, 029 pages were read in the last minute .
;
html public
- / / w3c / / dtd xhtml 1. 0 transitional / / en
urltoken
gp corp possess comprehensive varieties, fine operational network, professional and characterized services, and widely - recognized goodwill. being one of the leading pharmaceutical distributors in china, our sales revenue reached rmb 16. 9 billion .
phone: 86 8620 66281011 fax: 86862 - 08 - 1216498 urltoken no. employees: 21, 955 turnover: 3, 100. 56 (us $ m) financial year end: december
gp corp is the third largest pharmaceutical wholesaler nationally with around a 3% market share, and is the leader in its home province of guangdong with a market share of approximately 16% . guangdong has a population of around 78 million and enjoys one of the fastest growing gdp per capita in china. gp corp reported revenue of around £425 million for 2005, operates eight depots and has approximately 2, 000 employees. on completion of the transaction gp corp is expected to operate 29 retail pharmacies, this being the maximum permitted under current regulations for a 50: 50 foreign - invested joint venture such as gp corp .
the investment in gp corp will be made through a uk subsidiary in which beijing med - pharm corporation (
bmp
) holds a 20% stake. bmp is a us - listed pharmaceutical marketing and distribution company with existing operations and significant experience in china. the subsidiary will acquire a 50% interest in gp corp for a total consideration of around £38 million. alliance boots and bmp will fund the subsidiary pro - rata to their shareholdings. alliance boots will meet its investment from existing resources and will equity account for its interest in the joint venture .
commenting on the announcement, richard baker, alliance boots chief executive, said :
this is an exciting deal for alliance boots and underlies our commitment to be a major international player in pharmacy - led health and beauty. the chinese market has good growth potential and this move demonstrates our belief in the ability of the group to drive growth through developing opportunities in new markets .
stefano pessina, executive deputy chairman of alliance boots, with responsibility for strategy and m & a said :
the move into the chinese market demonstrates alliance boots' commitment to growing internationally and our attractiveness to partners. china is an exciting and important market for us to enter. this joint venture brings together strong local management and our extensive experience in running pharmaceutical wholesaling businesses. we expect gp corp to benefit from both the rapid expansion of the chinese healthcare market and further consolidation opportunities as they arise .
beijing med - pharm corporation (nasdaq: bjgp) is a pharmaceutical marketing and distribution company that offers the following services in china: pre - market entry analysis; clinical trial management; product registration; market research; pharmaceutical distribution to hospitals; and pharmaceutical marketing to healthcare providers .
alliance boots is a leading international pharmacy - led health and beauty group which operates in both wholesale and retail .
it has a wholesale and distribution network serving over 125, 000 pharmacies, hospitals and health centres via 380 depots in 14 countries. pharmaceutical wholesaling businesses are in the czech republic, france, italy, the netherlands, norway, russia, spain and the uk. associate pharmaceutical wholesaling interests are in egypt, germany, portugal, romania, switzerland and turkey .
in retail, alliance boots has a network of approximately 3, 000 outlets in seven countries, of which over 2, 700 have pharmacies. retail healthcare outlets are in republic of ireland, italy, the netherlands, norway, thailand and the uk. associate retail healthcare outlets are in italy and switzerland .
formed on 31 july 2006, alliance boots is listed on the london stock exchange and employs around 100, 000 people .
merrill lynch international acted as financial advisor to alliance boots. merrill lynch international is acting exclusively for alliance boots in connection with its investment in gp corp and for no one else .
this area is reserved for members of the news media. if you qualify, please update your user profile and check the box marked
check here to register as an accredited member of the news media
. please include any notes in the
supporting information for media credentials
box. we will notify you of your status via e - mail in one business day .
alex ferguson' jose' s learned lesson' fergie welcomes mourinho' s decision to be more humble, saying he' s learned lesson .
enclose phrases in quotes. use a + to require a term in results and - to exclude terms. example: + water - europe
© 2018 questex llc. all rights reserved. 275 grove street, suite 2 - 130 newton, ma 02466
despite the internal conflicts that led to a downfall of performance at the beginning of 1994 season, the club were managed to achieve 6 consecutive winnings later, which includes a 6 - 1 slaughter over shanghai shenhua fc, and were able to gain a runners - up spot at the 1994 season. peng weiguo, along with hu zhijun, became famous after that season .
in 2007, shen xiangfu – former head coach of the chinese olympic national team and beijing guoan fc – was named head coach of the club. with the signing of players including xu liang, li shuai, jia wenpeng and ramirez, the performance of the team had been improved greatly. with the support from the fans, the local government, media and other local enterprises, the club won the china league one title for the first time and was able to enter into the chinese super league .
the club continued to win their second league in the following season, becoming the first team in china to win the super league title twice in a row, while also securing the chinese fa cup and super cup to become triple winners in the year 2012 .
in 2014, alibaba group became another shareholder of the club by investing 1. 2 billion yuan to the club. the team claimed their fourth domestic league title during that year, and advanced to the quarterfinals of the afc champions league three times in a row .
charles r. walgreen sr. purchases the drugstore where he had worked as a pharmacist in chicago, u. s .
walgreens becomes the first major drugstore chain in the u. s. to put its prescriptions into child - resistant containers
alliance unichem acquires s. a. f. a. in spain boots becomes the largest retail pharmacy chain in ireland
walgreens and alliance boots form a strategic partnership to create the first global pharmacy - led, health and wellbeing enterprise walgreens opens its 8, 000th store in los angeles and acquires usa drug, a pharmacy chain in the mid - south u. s. walgreens and alliance boots form walgreens boots alliance development joint venture in bern, switzerland
walgreens boots alliance enters into long - term global supply chain agreement with fareva walgreens boots alliance receives regulatory clearance to purchase 1, 932 rite aid drugstores in the u. s .
walgreens boots alliance joins the dow jones industrial average as one of its 30 components .
expansion of the powder production line in korea (2. 2 million units per year )
first in the industry to achieve ohsas 18001 (safety and health management) certification .
acquired iljin pharmaceutical co. , ltd. as a subsidiary (by acquiring shares )
4, 5, 6, 7, 8 and 9th floor, building e, pangyo innovalley, 255, pangyo - ro, bundang - gu, seongnam - si, gyeonggi - do, korea tel. (031) 789 - 3000
copyright © 1999 - 2018 john wiley & sons, inc. all rights reserved
enter your email address below. if your address has been previously registered, you will receive an email with instructions on how to reset your password. if you don' t receive an email, you should register as a new user
* final gross price and currency may vary according to local vat and billing address. * your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. a link to download a pdf version of the drug profile will be included in your email receipt. adis is an information provider. we do not sell or distribute the pharmaceutical compounds written about in this database .
orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases .
oops, it looks like you don’t have a valid subscription to this content. to gain full access to the content and functionality of the adisinsight database try one of the following .
if you are a subscriber to this content then contact us at asktheexpert. adisinsight @ urltoken so we can help .
urltoken needs your explicit consent to store browser cookies. if you don' t allow cookies, you may not be able to use certain features of the web site such as personalized content. please see our privacy policy for more information .
welcome to our new website! if this is the first time you are logging in on the new site, you will need to reset your password. please contact us at raps @ urltoken if you need assistance .
the site navigation utilizes arrow, enter, escape, and space bar key commands. left and right arrows move across top level links and expand / close menus in sub levels. up and down arrows will open main level menus and toggle through sub tier links. enter and space open menus and escape closes them as well. tab will move on to the next part of the site rather than go through menu items .
the regulatory function is vital in making safe and effective healthcare products available worldwide. individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals .
one of our most valuable contributions to the profession is the regulatory code of ethics. the code of ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct .
your membership opens the door to free learning resources on demand. check out the member knowledge center for free webcasts, publications and online courses .
like all professions, regulatory is based on a shared set of competencies. the regulatory competency framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels .
join the brightest minds in regulatory at the annual regulatory convergence. see the global regulatory community in action. intensive workshops. topical sessions. meet ups with regulators. this is where it all comes together .
for 20 years, our flagship publication, fundamentals of us regulatory affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips .
there are hundreds of rac testing centers available worldwide. any of the four rac exams (us, eu, can or global) may be taken at any location. find an upcoming exam at a location near you .
as the us becomes increasingly dependent on chinese and indian active pharmaceutical ingredient (api) and drug manufacturing, a deeper look into the inspection reports from the us food and drug administration (fda) in china reveals a number of question marks that parallel the same sort of issues found in form 483s issued after inspections in india .
a focus review (thanks to use of the freedom of information act (foia) ) of eight fda form 483s for chinese manufacturers in 2015 paralleled some of the same data integrity deficiencies listed in the 50 form 483s focus reviewed back in november .
currently, 41 pharmaceutical manufacturing sites in china and five in hong kong are included on fda’s import alert list, which is a list of all the sites banned from shipping products to the us. china’s zhejiang hisoar pharmaceutical is the most recent addition (from 20 january) for good manufacturing practice deficiencies .
by comparison, there are 42 sites under import alert from india, though fda notes that some of those facilities listed are only banned for certain products and not the entire site .
but there are major differences between how fda operates in the two countries, which collectively account for about 80% of the world’s apis .
as of 18 december, fda told focus the agency has 17 employees assigned to the beijing office, including five new hires who have yet to deploy to china (only three of those five will work on drug - related issues). six employees from the fda’s china office were scheduled to begin conducting inspections from january to march, fda said, which would be a slight boost from a few months prior when fda only had two inspectors overseeing the roughly 700 manufacturing facilities there .
similarly in india, fda has plans to double the number of its inspectors there – from about nine to 19, though even if that number is actualized the agency would still be tasked with inspecting more than 500 manufacturing sites exporting products to the us .
concerns over how fda can adequately track the drug and api supply chain is starting to worry congress. in december, the house committee on energy & commerce sent a letter to the us government accountability office calling on the oversight office to investigate whether fda can adequately monitor the manufacturers in india and china, which in the past have had a history of counterfeiting, adulteration, substandard manufacturing and data falsification .
and though both china and india have domestic pharmaceutical inspectors and regulators (china fda and central drugs standards control organization, respectively), the standards used for these inspections are not yet on par with fda’s .
through the use of foia (form 483s are not generally released publicly by fda), focus found that more than 80 form 483s were issued to chinese manufacturers in 2015 after 132 inspections by fda staff. the 132 inspections is only 15 more than the number conducted in 2014, but up significantly from the paltry 19 inspections conducted in 2007, according to fda .
by comparison, fda conducted 203 inspections at indian manufacturing sites in 2015, up significantly from the 114 inspections conducted in 2014, and the 66 inspections from 2007 .
unfortunately, because of delays in the foia system and the cost of obtaining the documents, focus was only able to obtain eight of the 80 documents for review .
zhejiang hisoar pharmaceutical co. , the most recent addition to fda’s import alert list, was cited in a 483 by the agency after a three day inspection in august with seven observations. hisoar claims to manufacture four products for the us, four for the eu and three for japan, and lists pfizer, basf, sanofi and novartis among its partners .
among the most egregious observations are numerous data manipulation findings, in addition to the company’s failure to locate a logbook documenting the manufacture of apis, and individual equipment logs not including entries for uses of each piece of manufacturing equipment .
in addition, “sample raw data file names are altered in an attempt to hide deleted data files, ” fda inspectors said, noting the history of raw data modifications could not be tracked .
at chongqing kangle pharmaceutical co. ’s manufacturing site in chongqing, which the company claims is used mostly for producing anti - malarial apis and is not included on fda’s import alert list, inspectors found that a fan blows outside air onto raw ingredients used for api manufacturing, which poses contamination issues. fda also found “significant rust and flaking paint” in a wet chemistry quality control laboratory .
another facility that’s allowed to ship products to the us and claims to have customers in about 50 countries - - qilu tianhe pharmaceutical ’s manufacturing site in jinan, china - - was inspected by fda twice back in may and june, with 15 observations cited .
during an inspection of the company’s quality control lab, fda found partially incomplete or “otherwise undesirable” gas chromatography results were moved into an auxiliary folder entitled “test. ” the large number of sample sets within this test folder “containing tntc [ too numerous to count ] unreported sample injection results for finished apis prevented our comprehensive review of the results, ” fda said. these types of sample
tests
were also uncovered at indian manufacturing sites last year .
fda inspections at sites for hangzhou huadong medicine group kangrun pharmaceutical co. , ferring pharmaceutical, and shanghai desano chemical pharmaceutical co. also revealed data integrity questions, particularly around the control of computer and software systems, incomplete lab records of instrumentation calibration and sampling plans not based on scientific principles .
at shanghai desano - - which is part of a group of five member companies making about 20 apis and 15 finished products, mostly anti - virals, antibiotics and anti - malarials - - fda inspected one site last may and “noted the presence of what appear to be too numerous to count instances of unreported incidents required to be reported as manufacturing deviations. ”
the eight 483s also include one for pfizer’s dalian, china - based manufacturing site (though the 483 for another pfizer manufacturing site in fuyang city was not released by fda to focus). at the dalian site, fda officials found “the presence of uncontrolled records for a number of manufacturing records” which were supposed to be part of the company’s document control program. pfizer told bloomberg in october that it addressed the issues.
guangzhou pharmaceuticals corporation ( 广州医药集团 ) is a pharmaceutical wholesaling and distribution company headquartered in guangzhou , china , and a 50:50 joint venture between walgreens boots alliance and guangzhou pharmaceutical holdings limited . it is the third-largest pharmaceutical wholesaler in china measured by revenues . guangzhou pharmaceuticals wholesales prescription drugs , over-the-counter drugs , medical devices , chemical reagents , experiment equipment and glass wares . 
guangzhou pharmaceuticals corporation (广州医药集团) is a pharmaceutical wholesaling and distribution company headquartered in guangzhou, china, and a 50:50 joint venture between walgreens boots alliance and guangzhou pharmaceutical holdings limited. it is the third-largest pharmaceutical wholesaler in china measured by revenues. guangzhou pharmaceuticals wholesales prescription drugs, over-the-counter drugs, medical devices, chemical reagents, experiment equipment and glass wares.
guangzhou pharmaceuticals corporation (广州医药集团) is a pharmaceutical wholesaling and distribution company headquartered in guangzhou, china, and a 50:50 joint venture between walgreens boots alliance and guangzhou pharmaceutical holdings limited. it is the third-largest pharmaceutical wholesaler in china measured by revenues. guangzhou pharmaceuticals wholesales prescription drugs, over-the-counter drugs, medical devices, chemical reagents, experiment equipment and glass wares.